Researchers from the University of Manchester, working with Kenyatta National Hospital in Nairobi, have seen success in reversing high- and low-grade pre-cancerous disease of the cervix. Using the HIV antiviral drug lopinavir, a high proportion of women diagnosed with HPV positive high-grade disease returned to normal. Dr. Lynne Hampson, one of the researchers from the University of Manchester’s Institute of Cancer Sciences, notes that further work is needed, “but it looks as though this might be a potential treatment to stop early stage cervical cancer caused by HPV.” Read more about the study results and the potential impact they could have here: http://www.manchester.ac.uk/aboutus/news/display/?id=11595